Daily Courier: Single Column

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Idexx Laboratories (NQ: IDXX )

431.77 +5.66 (+1.33%)
Streaming Delayed Price Updated: 12:32 PM EST, Nov 13, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 154,334
Open 426.54
Bid (Size) 431.51 (6)
Ask (Size) 432.03 (6)
Prev. Close 426.11
Today's Range 425.79 - 432.81
52wk Range 404.74 - 583.39
Shares Outstanding 85,075,932
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Is It Time to Buy October's Worst-Performing Nasdaq Stocks?
Is it a good time to scoop up last month's biggest losers? Check out October's largest price drops on the Nasdaq, and see whether any of them look like good buys today. 
Via The Motley Fool
A Once-in-a-Decade Opportunity: 1 Super S&P 500 Stock Down 40% to Buy After Its Recent Pullback
Trading at its most reasonable valuation since 2016, this pet healthcare diagnostics leader could be a once-in-a-decade opportunity today. 
Via The Motley Fool
Topics Stocks
Exposures US Equities

Performance

YTD
-21.17%
-21.17%
1 Month
-9.67%
-9.67%
3 Month
-11.49%
-11.49%
6 Month
-17.14%
-17.14%
1 Year
-0.14%
-0.14%

More News

Read More
Decoding 5 Analyst Evaluations For IDEXX Laboratories
Via Benzinga
$1000 Invested In This Stock 10 Years Ago Would Be Worth $5,600 Today
Via Benzinga
CORRECTING and REPLACING IDEXX Laboratories Announces Third Quarter Results
From IDEXX Laboratories, Inc.
Via Business Wire
What Analysts Are Saying About IDEXX Laboratories Stock
Via Benzinga
$100 Invested In This Stock 20 Years Ago Would Be Worth $1,000 Today
Via Benzinga
$100 Invested In IDEXX Laboratories 20 Years Ago Would Be Worth This Much Today
Via Benzinga
Idexx Laboratories Adjusts Guidance As Q3 Revenue Growth Slows, Analyst Notes Fewer Veterinary Visits, Looks Towards Long-Term Growth
Via Benzinga
IDEXX Laboratories to Release 2024 Third Quarter Financial Results
From IDEXX Laboratories, Inc.
Via Business Wire
Here's How Much You Would Have Made Owning IDEXX Laboratories Stock In The Last 10 Years
Via Benzinga
Here's How Much You Would Have Made Owning IDEXX Laboratories Stock In The Last 15 Years
Via Benzinga
IDEXX Laboratories to Present at Morgan Stanley 22nd Annual Global Healthcare Conference
From IDEXX Laboratories, Inc.
Via Business Wire
$100 Invested In This Stock 10 Years Ago Would Be Worth $800 Today
Via Benzinga
Analyst Ratings For IDEXX Laboratories
Via Benzinga
Animal Health Firm Idexx's Robust Business Model Bolsters Position Despite Slower Growth, Says Analyst
Via Benzinga
IDXX Stock Earnings: IDEXX Laboratories Beats EPS, Beats Revenue for Q2 2024
Via InvestorPlace
IDEXX Laboratories Announces Second Quarter Results
From IDEXX Laboratories, Inc.
Via Business Wire
IDEXX Laboratories Announces Time Change for 2024 Second Quarter Financial Results Conference Call
From IDEXX Laboratories, Inc.
Via Business Wire
Here's How Much $100 Invested In IDEXX Laboratories 20 Years Ago Would Be Worth Today
Via Benzinga
P/E Ratio Insights for IDEXX Laboratories
Via Benzinga
Looking Into IDEXX Laboratories's Recent Short Interest
Via Benzinga
$100 Invested In This Stock 10 Years Ago Would Be Worth $700 Today
Via Benzinga
7 ‘Lottery Ticket Stocks’ That Could Turn $1K into $10K
Via InvestorPlace
IDEXX Laboratories to Release 2024 Second Quarter Financial Results
From IDEXX Laboratories, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

© Copyright 2015, Daily Courier, Kelowna, BC. Powered by BLOX Content Management System from TownNews.com.